A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B
Clinical trial NCT04180150 · UNKNOWN
Trial details
- NCT number
- NCT04180150
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-18
- Primary completion
- 2020-09-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.